Cue Biopharma, INC. (CUE) — 10-Q Filings

10-Q Filings (6)

• Cue Biopharma Narrows Losses, Boosts Cash with ImmunoScape Deal — Nov 12, 2025 Risk: high
  Cue Biopharma, Inc. reported a net loss of $7.448 million for the three months ended September 30, 2025, an improvement from a net loss of $8.660 million in the
• Cue Biopharma Narrows Q2 Loss Amidst Zero Revenue — Aug 12, 2025 Risk: high
  Cue Biopharma, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, indicating its pre-commercial
• Cue Biopharma Files Q1 2025 10-Q, Cites Warrant Activity — May 12, 2025 Risk: medium
  Cue Biopharma, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Imagen Biopharma, Inc., is in the pharmaceutical preparations ind
• Cue Biopharma Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  Cue Biopharma, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results and provided updates on its business operati
• Cue Biopharma Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  Cue Biopharma, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business operatio
• Cue Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  Cue Biopharma, Inc. (CUE) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Cue Biopharma, Inc. filed a 10-Q report for the period ending March 31, 2

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX